Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immix Biopharma, Inc. - Common Stock (NQ:IMMX)

9.635 +0.175 (+1.85%)
Streaming Delayed Price Updated: 3:35 PM EDT, Mar 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Immix Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
News headline image
23 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... 
Via Benzinga
News headline image
EXCLUSIVE: Immix CEO On FDA Designation, Positioning, Price Action On 'Benzinga Live' ↗
Immix Biopharma Inc (NASDAQ: IMMX) stock is soaring Monday after the U.S. Food and Drug Administration granted Rare Pediatric Disease designation for IMX-110 for the... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges 150 Points; Applied Therapeutics Shares Slide ↗
Toward the end of trading Monday, the Dow traded up 0.43% to 36,496.18 while the NASDAQ rose 0.93% to 15,790.97. The S&P also rose, gaining 0.43% to 4,786.68. The U.S. has the... 
Via Benzinga
News headline image
61 Biggest Movers From Yesterday ↗
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's stock is trading at a volume of 101.5 million... 
Via Benzinga
News headline image
Dow Flat as Tesla Lifts Tech, Autos ↗
The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black. 
Via Talk Markets
News headline image
Mid-Day Market Update: Gold Down 1%; Immix Biopharma Shares Spike Higher ↗
Midway through trading Monday, the Dow traded up 0.18% to 36,402.21 while the NASDAQ rose 0.75% to 15,762.21. The S&P also rose, gaining 0.23% to 4,776.99. The U.S. has the... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-... 
Via Benzinga
News headline image
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE ↗
We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. 
Via InvestorPlace
News headline image
BLCT Stock: 7 Things to Know About LGBT Platform BlueCity Holdings and the Spriver Tech Deal ↗
BlueCity Holdings (BLCT) has announced an offer for the company's stock from Baoli Ma and Spriver Tech Limited and we've got the details. 
Via InvestorPlace
News headline image
IMMX Stock Alert: The Massive FDA Win That Has Immix Biopharma Blasting Higher Today ↗
Immix Biopharma (IMMX) stock is taking off Monday thanks to a Rare Pediatric Disease designation from the U.S. Food and Drug Administration. 
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Edge Higher; Tesla Q4 Deliveries Top Estimates ↗
Following the market opening Monday, the Dow traded up 0.11% to 36,378.68 while the NASDAQ rose 0.18% to 15,673.75. The S&P also rose, gaining 0.11% to 4,771.56. The U.S. has... 
Via Benzinga
News headline image
Immix Shares Rally On FDA Rare Pediatric Disease Tag For Cancer Program In Children ↗
The FDA has granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma Inc's (NASDAQ: IMMX) IMX-110 for rhabdomyosarcoma, a form of... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million.... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2... 
Via Benzinga
News headline image
4 Penny Stocks Insiders Are Buying ↗
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
News headline image
65 Biggest Movers From Yesterday ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... 
Via Benzinga
News headline image
38 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday! 
Via InvestorPlace
News headline image
25 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index. Verso Corporation (NYSE:... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week ↗
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some... 
Via Talk Markets
News headline image
63 Biggest Movers From Friday ↗
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week ↗
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also... 
Via Benzinga
News headline image
Opening Day: Samsara Pops In Trading Debut After IPO Raises $805M ↗
Shares of software maker Samsara rose over 7% in the stock's trading debut following a $805 million IPO. The company is the pioneer of the Connected Operations Cloud, which allows businesses to develop... 
Via Talk Markets
News headline image
28 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday! 
Via InvestorPlace
News headline image
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.